Validation of a guideline-based composite outcome assessment tool for asthma control

por Spencer, Sally, Mayer, Bhabita, Bendall, Kate L, Bateman, Eric D
Publicado 2007

Asthma management in low and middle income countries: case for change

por Mortimer, Kevin, Reddel, Helen K., Pitrez, Paulo M., Bateman, Eric D.
Publicado 2022

Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”

por Samuelsen, Carl, Bateman, Eric D., Pavord, Ian, Lloyd, Adam, Baldwin, Mike, Esser, Dirk
Publicado 2015

Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom

por Samyshkin, Yevgeniy, Kotchie, Robert W., Mörk, Ann-Christin, Briggs, Andrew H., Bateman, Eric D.
Publicado 2013

Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β(2)-agonists in patients with atopic asthma

por Bateman, Eric D, O’Brien, Christopher, Rugman, Paul, Luke, Sally, Ivanov, Stefan, Uddin, Mohib
Publicado 2018

Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study

por Bateman, Eric D., Ferguson, Gary T., Barnes, Neil, Gallagher, Nicola, Green, Yulia, Henley, Michelle, Banerji, Donald
Publicado 2013

Global asthma prevalence in adults: findings from the cross-sectional world health survey

por To, Teresa, Stanojevic, Sanja, Moores, Ginette, Gershon, Andrea S, Bateman, Eric D, Cruz, Alvaro A, Boulet, Louis-Philippe
Publicado 2012

Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study

por Woodcock, Ashley, Lötvall, Jan, Busse, William W, Bateman, Eric D, Stone, Sally, Ellsworth, Anna, Jacques, Loretta
Publicado 2014

Correction to: Global asthma prevalence in adults: findings from the cross-sectional world health survey

por To, Teresa, Stanojevic, Sanja, Moores, Ginette, Gershon, Andrea S., Bateman, Eric D., Cruz, Alvaro A., Boulet, Louis-Philippe
Publicado 2021

Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (A...

por Bateman, Eric D., Chapman, Kenneth R., Singh, Dave, D’Urzo, Anthony D., Molins, Eduard, Leselbaum, Anne, Gil, Esther Garcia
Publicado 2015

Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment

por Jenkins, Christine R., Eriksson, Göran, Bateman, Eric D., Reddel, Helen K., Sears, Malcolm R., Lindberg, Magnus, O’Byrne, Paul M.
Publicado 2017

Implementing nurse-initiated and managed antiretroviral treatment (NIMART) in South Africa: a qualitative process evaluation of the STRETCH trial

por Georgeu, Daniella, Colvin, Christopher J, Lewin, Simon, Fairall, Lara, Bachmann, Max O, Uebel, Kerry, Zwarenstein, Merrick, Draper, Beverly, Bateman, Eric D
Publicado 2012

Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multi...

por Singh, Dave, Jones, Paul W, Bateman, Eric D, Korn, Stephanie, Serra, Cristina, Molins, Eduard, Caracta, Cynthia, Gil, Esther Garcia, Leselbaum, Anne
Publicado 2014

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

por Woodcock, Ashley, Bateman, Eric D, Busse, William W, Lötvall, Jan, Snowise, Neil G, Forth, Richard, Jacques, Loretta, Haumann, Brett, Bleecker, Eugene R
Publicado 2011

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

por Woodcock, Ashley, Bleecker, Eugene R, Busse, William W, Lötvall, Jan, Snowise, Neil G, Frith, Lucy, Jacques, Loretta, Haumann, Brett, Bateman, Eric D
Publicado 2011

Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma: A Randomi...

por Woodcock, Ashley, Bleecker, Eugene R., Lötvall, Jan, O’Byrne, Paul M., Bateman, Eric D., Medley, Hilary, Ellsworth, Anna, Jacques, Loretta, Busse, William W.
Publicado 2013

Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma

por O’Byrne, Paul M., Bleecker, Eugene R., Bateman, Eric D., Busse, William W., Woodcock, Ashley, Forth, Richard, Toler, William T., Jacques, Loretta, Lötvall, Jan
Publicado 2014

Comparison of vilanterol, a novel long-acting beta(2) agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids

por Lötvall, Jan, Bateman, Eric D, Busse, William W, O’Byrne, Paul M, Woodcock, Ashley, Toler, William T, Jacques, Loretta, Goldfrad, Caroline, Bleecker, Eugene R
Publicado 2014

Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial

por O’Byrne, Paul M, Woodcock, Ashley, Bleecker, Eugene R, Bateman, Eric D, Lötvall, Jan, Forth, Richard, Medley, Hilary, Jacques, Loretta, Busse, William W
Publicado 2014

Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis

por Allwood, Brian W, Maasdorp, Elizna, Kim, Grace J, Cooper, Christopher B, Goldin, Jonathan, van Zyl-Smit, Richard N, Bateman, Eric D, Dawson, Rodney
Publicado 2020